Dr. Gross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7150 Greenville Ave
Ste 305
Dallas, TX 75231Phone+1 214-369-6434Fax+1 214-696-6273
Education & Training
- Boston Children's HospitalFellowship, Pediatric Ophthalmology, 1984
- Boston University Medical CenterResidency, Ophthalmology, 1983
- McGaw Medical Center of Northwestern UniversityResidency, Ophthalmology, 1980 - 1981
- Baylor University Medical CenterInternship, Internal Medicine, 1979 - 1980
- University of Texas Southwestern Medical SchoolClass of 1979
- University of North TexasMBA, Management, 1976 - 1978
Certifications & Licensure
- AZ State Medical License 1982 - 2026
- NM State Medical License 1983 - 2025
- TX State Medical License 1979 - 2025
- AR State Medical License 1989 - 2024
- CA State Medical License 1981 - 2024
- IL State Medical License 1980 - 1987
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Best Doctors and Pediatric Specialists D Magazine, 2016-2018
- Senior Honor Award American Association for Pediatric Ophthalmology & Strabismus, 2017
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsPreclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.Cullen T. Vogelson, Mark B. Abelson, Terri Pasquine, Donna M Stephens, Daniel A. Gamache
Allergy and Asthma Proceedings. 2004-01-01 - 7 citationsSafety and Tolerability of Olopatadine 0.2% in Children and AdolescentsSteven J. Lichtenstein, Terry A. Pasquine, Michael R. Edwards, David T. Wells, Robert D. Gross
Journal of Ocular Pharmacology and Therapeutics. 2007-09-05 - 26 citationsClinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a random...Mark B. Abelson, Paul J Gomes, Cullen T. Vogelson, Terri Pasquine, Robert D. Gross
Clinical Therapeutics. 2004-08-01
Professional Memberships
- Fellow
- Fellow
- Fellow
- Member
- Member
- American Association for Pediatric Ophthalmology &StrabismusMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: